Loading company…
SynthioLabs develops AI tools for compliant engagement between pharmaceutical companies and healthcare professionals.
Founded in 2024 and based in San Francisco, US, SynthioLabs develops AI tools for life sciences, including Nexa for physician engagement and Synthio Polaris for custom AI agents. It serves pharmaceutical companies, including 10 of the top 20 firms. In November 2025, it raised USD 5 million in Seed funding from Elevation Capital, 1984, Peak XV Partners, Y Combinator and individual investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in